Research ArticleResearchPatient EducationWorkflow

Randomized trial of 90 gastrointestinal cancer surgery patients finds individualized AI-assisted discharge nutrition boosts protein and caloric adequacy

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (PubMed)Oct 29, 2026

Read original source

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A randomized controlled trial of 90 patients recovering from gastric or colorectal cancer surgery found that individualized, clinician-supervised nutritional guidance generated with AI assistance significantly increased 30-day caloric adequacy from 40.0% to 66.7% and protein adequacy from 35.6% to 62.2% while reducing GI symptoms.

What NurseJet pulled from the source

Postoperative nutritional deficits and gastrointestinal symptoms frequently plague patients following surgical resection for gastrointestinal malignancies, yet hospital discharge advice often remains generic and difficult to operationalize at home. In this single-center, parallel-group randomized controlled trial, 90 patients undergoing laparoscopic gastric or colorectal cancer surgery were randomized 1:1 to receive either clinician-reviewed AI-facilitated individualized nutritional guidance (utilizing DeepSeek v3.2 with ABC-structured prompting) or standard discharge dietary advice. At 30 days post-discharge, the intervention cohort achieved significantly greater energy intake adequacy (>=90% of caloric target: 66.7% vs 40.0%, odds ratio [OR] 3.0, 95% CI: 1.3–7.1; p = 0.01) and protein adequacy (62.2% vs 35.6%, OR 2.9, 95% CI: 1.2–6.8; p = 0.01). Patients receiving individualized guidance reported significant improvements in postoperative fatigue, nausea, vomiting, appetite loss, and overall gastrointestinal symptom burden (Gastrointestinal Symptom Rating Scale [GSRS] score 2.1 vs 2.5, p = 0.03). Clinician preparation time fell from 12.5 minutes to 8.2 minutes per patient (p < 0.001), while 30-day complication rates and weight trajectory did not differ.

Why this matters for nurses

Surgical oncology nurses coordinate complex discharge plans for patients with altered gastrointestinal anatomy. Malnutrition and debilitating symptoms like nausea and early satiety commonly trigger avoidable rehospitalizations. Demonstrating that personalized, quantified meal guidance significantly boosts nutritional adherence and suppresses symptom distress provides bedside and clinic nurses with an actionable model for enhancing discharge education through supervised digital tools.

Bedside takeaway

An RCT of 90 post-op gastrointestinal cancer patients showed clinician-reviewed individualized discharge nutrition plans boosted 30-day caloric adequacy from 40% to 66.7%.

Key takeaways

Randomized trial evaluated 90 patients following laparoscopic gastric or colorectal cancer surgery.
Individualized, clinician-reviewed discharge guidance increased caloric adequacy to 66.7% vs 40.0% with standard care (p = 0.01).
Protein intake adequacy improved substantially from 35.6% to 62.2% (p = 0.01).
Patient-reported symptoms of nausea, vomiting, fatigue, and appetite loss were significantly mitigated at 30 days post-discharge.
Clinician drafting time decreased by 34% (8.2 vs 12.5 minutes), demonstrating operational efficiency without compromising clinical oversight.

Practice implications

Prior to discharge following gastrointestinal resections, provide patients with specific, quantified daily protein and caloric targets tailored to their surgical anatomy and food preferences, emphasizing small, nutrient-dense meals and ongoing symptom monitoring.

Limitations & cautions

Single-center design in 90 surgical patients; intervention evaluated a combined bundle of structured prompts, individualization, and clinician review, preventing isolation of the AI component alone; no significant differences were seen in 30-day complications or weight preservation.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (PubMed)

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (PubMed). AI-facilitated individualized nutritional guidance with ABC-structured prompts improves short-term dietary intake adequacy and patient-reported symptoms after gastrointestinal cancer surgery: a randomized controlled trial.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42955117/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

The American journal of emergency medicine (PubMed)Jul 27, 2026Systematic Review

An updated systematic review and meta-analysis of five randomized controlled trials comprising 404 chest trauma patients demonstrated that applying suction following tube thoracostomy significantly shortened chest tube duration by 2.95 days and hospital stay by 3.98 days compared with water seal.

Med-Surg EmergencyAI summaryReview source

Systematic ReviewResearchWorkflowAI summary · original source linked below

Optimal drainage management following tube thoracostomy for traumatic pneumothorax and hemothorax remains a subject of ongoing clinical debate between continuous suction and passive water seal systems. In this updated systematic review and meta-analysis searching PubMed, Embase, Web of Science, and Cochrane CENTRAL through May 2026, researchers pooled data from five randomized controlled trials encompassing 404 trauma patients. Compared to water seal management, suction significantly reduced chest tube duration (mean difference [MD]: -2.95 days, 95% CI: -4.58 to -1.31; p = 0.0004) and hospital length of stay (MD: -3.98 days, 95% CI: -5.70 to -2.27; p < 0.00001). Furthermore, suction significantly increased the likelihood of achieving full lung expansion (OR: 4.86, 95% CI: 1.70–13.88; p = 0.003). Minimal clinically important difference (MCID) analysis confirmed meaningful benefits across all three parameters. Rates of recurrent pneumothorax, re-intervention, and retained or clotted hemothorax did not differ significantly between groups.

Key takeaways

Meta-analysis synthesized 5 randomized controlled trials comprising 404 patients with traumatic chest injuries.
Continuous suction shortened chest tube indwelling duration by nearly three days (MD -2.95 days, p = 0.0004).
Hospital length of stay was significantly reduced by approximately four days with suction (MD -3.98 days, p < 0.00001).
Patients on suction were nearly five times more likely to achieve full lung expansion (OR 4.86, p = 0.003).
No significant differences were identified in recurrent pneumothorax, clotted hemothorax, or re-intervention rates.

Why this matters on shift

Surgical and medical-surgical nurses care daily for trauma patients with chest drainage systems. Tube thoracostomy carries substantial pain, impairs pulmonary mechanics, and limits ambulation. Demonstrating that proactive suction management promotes faster pleural re-expansion and significantly reduces both tube duration and hospital stay provides bedside nurses and trauma teams with evidence to question prolonged passive water seal strategies in traumatic injury.

Bedside takeaway

A meta-analysis of 5 RCTs and 404 trauma patients found suction after tube thoracostomy reduced chest tube duration by 2.95 days and hospital stay by 3.98 days compared to water seal.

Nursing implications

Monitor chest drainage systems actively according to provider orders; when suction is prescribed, maintain prescribed negative pressure (-20 cm H2O), assess air leak chambers and drainage volumes regularly, and facilitate early incentive spirometry to optimize lung expansion.

Limitations & cautions

All included trials exhibited high risk of bias due to lack of clinician and outcome assessor blinding, which could influence subjective removal decisions; small sample size (404 patients across 5 trials) limited statistical power to assess complications such as clotted hemothorax.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

The American journal of emergency medicine (PubMed). Comparative effectiveness of suction versus water seal following tube thoracostomy in traumatic pneumothorax and hemothorax: An updated systematic review and meta-analysis.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

American journal of infection control (PubMed)Jun 18, 2026Research Article

A multicenter trial across four nursing homes involving 580 short-stay admissions revealed that documented MDRO history correctly identified only 25% of residents actively colonized with multidrug-resistant organisms on admission surveillance cultures.

Geriatrics Med-SurgAI summaryReview source

Research ArticleResearchInfection ControlPolicyAI summary · original source linked below

Nursing home residents have a high prevalence of multidrug-resistant organism (MDRO) colonization, leading CDC guidance to recommend Enhanced Barrier Precautions (EBP) during high-contact care for residents with chronic wounds, indwelling medical devices, or documented MDRO colonization. This prospective study evaluated admission surveillance cultures during a clinical trial (ClinicalTrials.gov NCT03319368) across four Maryland nursing homes to determine the real-world accuracy of EBP indications. Among 580 primarily short-stay admissions, 31% met at least one CDC EBP indication: 21% had a prior MDRO history, 13% had an indwelling medical device, and 9% had a chronic wound. Prospective microbiological surveillance of anterior nares and inguinal skin detected active MDRO colonization in 21% (122/580) of residents. Notably, only 25% of residents with a documented MDRO history were culture-positive on admission, and conversely, only 25% of culture-positive residents had an established MDRO history in their transfer medical record. Novel or targeted pathogens were exceptionally rare: only one resident harbored carbapenemase-producing Gram-negative bacilli, and zero had Candidozyma auris.

Key takeaways

Prospective trial assessed admission MDRO surveillance cultures across 580 nursing home residents in four facilities.
Thirty-one percent of residents met CDC Enhanced Barrier Precaution indications on admission.
Active MDRO colonization was confirmed by culture in 21% of admissions.
Documented MDRO history had poor sensitivity and specificity, identifying only 25% of culture-positive residents while 75% of colonized residents lacked any documented history.
Findings affirm CDC emphasis on universal device- and wound-based triggers rather than relying on inconsistent transfer chart histories.

Why this matters on shift

Geriatric and long-term care nurses balance infection prevention with resident autonomy, dignity, and socialization. Relying primarily on past medical chart flags to initiate contact precautions creates blind spots where unflagged carriers spread resistant pathogens while formerly colonized residents endure unnecessary isolation. Understanding these diagnostic gaps reinforces why nurses must consistently practice gown-and-glove precautions during high-contact care for all residents with indwelling devices and chronic wounds regardless of documented history.

Bedside takeaway

A trial in 580 nursing home residents found documented MDRO history identified only 25% of actively colonized patients, underscoring the need for device- and wound-based precautions.

Nursing implications

Implement Enhanced Barrier Precautions during high-contact nursing activities (such as dressing, bathing, transferring, and device care) based rigorously on the presence of indwelling devices or open wounds rather than awaiting MDRO chart alerts, while upholding standard precautions for all residents.

Limitations & cautions

Conducted in four facilities within a single geographic region (Maryland) among predominantly short-stay rehabilitation admissions; culturing was restricted to anterior nares and inguinal skin, potentially underestimating perianal or gastrointestinal colonization.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

American journal of infection control (PubMed). Improving infection control in nursing homes: Enhanced barrier precautions and multidrug-resistant organism colonization.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

JAMA (PubMed)Oct 24, 2026Systematic Review

A systematic review and meta-analysis of 85 randomized controlled trials encompassing 70,543 participants found that SGLT2 inhibitor therapy was associated with small, statistically significant increases in hemoglobin (+0.60 g/dL), hematocrit (+2.36%), and erythropoietin (+2.11 mIU/mL).

Med-Surg TelemetryAI summaryReview source

Systematic ReviewResearchMedication SafetyAI summary · original source linked below

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are widely prescribed across chronic heart failure, type 2 diabetes, and chronic kidney disease, where retrospective observations frequently note concurrent elevations in red blood cell indices. In this systematic review and meta-analysis searching PubMed, Web of Science, and CENTRAL through July 22, 2026, researchers pooled data from 85 double-masked randomized clinical trials (median duration 24 weeks; IQR 12–32 weeks) covering 70,543 patients (mean age 62.4 +/- 9.4 years; 35.9% female). Seventy-eight trials compared SGLT2 inhibitors against placebo, and seven utilized active comparators (primarily sitagliptin). From baseline to follow-up, hemoglobin increased by 0.55 g/dL with SGLT2 inhibitors versus a 0.08 g/dL decrease in control cohorts (net between-group difference 0.60 g/dL, 95% CI: 0.55–0.66 g/dL; p < 0.001). Hematocrit changed by +2.17% versus -0.13% in controls (difference 2.36%, 95% CI: 2.19%–2.52%; p < 0.001). Analysis of secondary erythropoietic and iron parameters demonstrated a significant increase in serum erythropoietin (difference 2.11 mIU/mL, 95% CI: 0.50–3.71; p = 0.01) and a significant reduction in transferrin saturation (difference -0.84%, 95% CI: -1.21% to -0.47%; p < 0.001).

Key takeaways

Systematic review analyzed 85 double-masked RCTs encompassing 70,543 patients across cardiology, nephrology, and endocrinology.
SGLT2 inhibitors produced modest but statistically significant increases in hemoglobin (+0.60 g/dL) and hematocrit (+2.36%).
Therapy was associated with stimulated erythropoiesis, evidenced by an increase in serum erythropoietin (+2.11 mIU/mL, p = 0.01).
Transferrin saturation decreased slightly (-0.84%, p < 0.001), reflecting increased iron utilization during erythropoiesis.
Authors emphasized that clinical significance remains uncertain and SGLT2 inhibitors should not be prescribed for the primary intent of treating anemia.

Why this matters on shift

Nurses administer SGLT2 inhibitors (such as empagliflozin, dapagliflozin, and canagliflozin) daily on medical-surgical, cardiac, and renal units. When reviewing routine complete blood count panels, nurses observing slight elevations in hemoglobin or hematocrit must recognize this as a known physiologic class effect mediated by hemoconcentration and mild erythropoietin stimulation, rather than misinterpreting it as acute dehydration or treating SGLT2 inhibitors as an anemia cure.

Bedside takeaway

In a meta-analysis of 85 RCTs and 70,543 patients, SGLT2 inhibitors led to small increases in hemoglobin (+0.60 g/dL) and erythropoietin (+2.11 mIU/mL), though clinical significance is unclear.

Nursing implications

Anticipate modest increases in hemoglobin and hematocrit when monitoring patients on SGLT2 inhibitors; differentiate expected class-related hemoconcentration and erythropoietin stimulation from acute volume depletion, and continue reinforcing fluid balance and medication adherence.

Limitations & cautions

The observed hematologic elevations were small (+0.60 g/dL hemoglobin), and the clinical importance of these changes remains unproven; trials were not designed to test clinical anemia endpoints or symptomatic benefit; SGLT2 inhibitors are not approved for anemia therapy.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

JAMA (PubMed). Sodium-Glucose Cotransporter 2 Inhibitor Use and Levels of Hemoglobin, Markers of Iron Metabolism, and Erythropoiesis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Meta-analysis of 404 chest trauma patients finds post-thoracostomy suction reduces chest tube duration by 3 days and hospital stay by 4 days versus water seal

Trial of 580 nursing home admissions shows documented MDRO history identifies only 25% of active colonizations, challenging routine precaution triggers

Meta-analysis of 85 randomized trials and 70,543 patients links SGLT2 inhibitors to small increases in hemoglobin and erythropoietin